$AVGO Avicena Group, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Avicena Group, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Avicena Group, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Avicena Group, Inc. for free.

CIK Number: 0001317092
IRS Number: 043195737
Industry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Trading Symbol: AVGO
Company Address: 228 HAMILTON AVENUE, THIRD FLOOR PALO ALTO 94301

Market Capitalization: $82.70B
Prev close: $206.89
Average Daily Volume: 2,989,290
Days Low: $207.09
Year Low: $114.25
Year High: $208.75

Avicena Group, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 19 2007AVGOAvicena Group, Inc ...Sagman UriDirectorOption ExerciseA5.75275,0001,581,250275,000
Apr 19 2007AVGOAvicena Group, Inc ...Sullivan MichaelChief Financial Off ...Option ExerciseA5.75150,000862,500150,000
Nov 28 2005AVGOAvicena Group, Inc ...SCHIMMEL PAULDirectorOption ExerciseC0.0033,24200
Nov 28 2005AVGOAvicena Group, Inc ...SCHIMMEL PAULDirectorBuyC0.0033,24201,205,2421.2 M to 1.2 M (+2.84 %)
Nov 28 2005AVGOAvicena Group, Inc ...MENHALL NASSERDirectorOption ExerciseC0.00142,80000
Nov 28 2005AVGOAvicena Group, Inc ...MENHALL NASSERDirectorBuyC0.00142,80001,279,8101.1 M to 1.3 M (+12.56 %)
Nov 28 2005AVGOAvicena Group, Inc ...Gertler Andrew MDirectorGrantA0.0050,000050,0000 to 50 K
Nov 28 2005AVGOAvicena Group, Inc ...Galda Joseph PaulDirectorGrantA0.0050,000050,0000 to 50 K
Nov 28 2005AVGOAvicena Group, Inc ...Nivaggioli Belinda TsaoChief Executive Off ...Option ExerciseC0.00140,00100
Nov 28 2005AVGOAvicena Group, Inc ...Nivaggioli Belinda TsaoChief Executive Off ...BuyC0.00140,00103,000,9612.9 M to 3 M (+4.89 %)

View all Avicena Group, Inc. insider transactions.